In:

Annals of Clinical Microbiology and Antimicrobials

Authors:

Alfonso J. Rodriguez‑Morales, Antonio Carlos Bandeira and Carlos Franco‑Paredes

During recent years, but particularly since 2015, concern on Zika virus has grown for multiple reasons, such as its association with the occurrence of Guillain–Barré syndrome and microcephaly [1, 2]. Nevertheless, in addition to all epidemiological implications of the outbreak in Latin America [3] the number of affected cases continue to rise and expected to reach over four million in 2016, adding to this the possibility of new modes of transmission.

Download full publication: